HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Kasukabe Selected Research

MS 430

2/2001Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Kasukabe Research Topics

Disease

2Myeloid Leukemia (Leukemia, Myelocytic)
05/2001 - 02/2001
2Leukemia
02/2001 - 08/2000
1Neoplasms (Cancer)
08/2000
1Carcinoma (Carcinomatosis)
07/2000
1Lymphoma (Lymphomas)
07/2000

Drug/Important Bio-Agent (IBA)

1Sirolimus (Rapamycin)FDA Link
05/2001
1CalciumIBA
05/2001
1Calmodulin (Calcium-Dependent Activator Protein)IBA
05/2001
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2001
1Phosphotransferases (Kinase)IBA
05/2001
1Tacrolimus (Prograf)FDA LinkGeneric
05/2001
1MacrolidesIBA
05/2001
1Pharmaceutical PreparationsIBA
02/2001
1pyrimidineIBA
02/2001
1MS 430IBA
02/2001
12'-deoxyadenosineIBA
08/2000
1Pentostatin (Nipent)FDA LinkGeneric
08/2000
1AntimetabolitesIBA
07/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
07/2000